DEMOCRATIC REPUBLIC OF THE CONGO / RankWire.AI / – In Congo, the Ebola outbreak has expanded more rapidly than any previous epidemic in the country. As of August 3, officials documented 3,874 confirmed cases and 1,751 deaths. This outbreak is now Congo’s largest recorded Ebola event and ranks as the second-largest worldwide. The country hit the 1,000-case mark within 40 days of initiating its response, whereas the major outbreak that started in 2018 took approximately 235 days to surpass that number.
Health authorities announced the outbreak on May 15, following laboratory confirmation of Bundibugyo virus in Ituri province. Later investigations indicated that infections had begun months earlier near Mongbwalu. Many early patients exhibited symptoms similar to malaria and other common illnesses. Initial testing focused on the better-known Zaire Ebola strain. The late recognition allowed the virus to spread extensively within households, clinics, mining sites, and trading communities before testing and isolation measures could be scaled up.
The presence of the Bundibugyo strain has also limited available medical interventions for responders. Vaccines and antibody treatments approved for Ebola target Zaire ebolavirus, which was responsible for Congo’s epidemic from 2018 to 2020. Currently, no licensed vaccine or proven specific treatment exists for Bundibugyo virus disease. Medical teams must rely on rapid diagnostics, patient isolation, supportive care, infection control practices, and safe burial protocols. Although the World Health Organization has supported enhanced diagnostic capacity and treatment research, these efforts began only after the virus had already transmitted widely in multiple regions.
Delayed detection hampered contact tracing
The epidemic has extended beyond Mongbwalu into numerous health zones across eastern and northeastern Congo. Ituri remains the central hub, with additional cases reported in North Kivu, South Kivu, Haut-Uele, and Tshopo. By July 30, response teams had monitored 17,863 contacts, but follow-up has been inconsistent, especially in provinces affected by insecurity and difficult terrain. Many new patients have been identified outside of known contact lists, indicating gaps in surveillance that have failed to identify every transmission chain.
Ongoing conflict has further complicated case detection and patient management. Armed assaults have blocked roads, hampered health activities, and caused some teams to halt fieldwork temporarily. Additionally, large-scale movement between mining sites, markets, towns, and displacement camps makes daily contact monitoring difficult. Healthcare facilities are also experiencing shortages of protective gear, trained personnel, transportation, and laboratory access. As of July 30, Congo had recorded 151 infections and 44 deaths among healthcare workers, intensifying the strain on the response system.
Inadequate vaccination coverage and insecurity fuel transmission
Ebola transmits mainly through direct contact with blood or bodily fluids of infected individuals. Risk is heightened in homes, clinics, and burial sites where infection control measures are weak. Over 60% of recent fatalities occurred outside treatment centers, complicating safe burials and contact tracing efforts. In response, the World Health Organization, Congo’s health ministry, and Africa CDC have expanded laboratory testing, treatment facilities, border screenings, and public outreach campaigns. Despite these efforts, the pace and geographical scope of new cases continue to outstrip response capabilities.
Uganda declared the end of its related Ebola outbreak on July 28 after 42 days without new cases, and France reported no secondary transmissions from its single treated patient. Congo remains the primary source of ongoing transmission, with a case fatality rate near 45% as of early August. The accelerated spread is attributed to late detection, the absence of strain-specific vaccines and treatments, missed contact identifications, ongoing conflict, staffing shortages, and high population mobility. These factors distinguish the current Bundibugyo epidemic from previous Ebola outbreaks in Congo.